Fresh Frozen Plasma Plus Iron Therapy in Congenital Hypotransferrinemia in the Second Decade: A Dynamic Approach to Maintaining Hematological Stability

Kaynakça (10)

1. Goldwurm S, Casati C, Venturi N, Strada S, Santambrogio P, Indraccolo S, Arosio P, Cazzola M, Piperno A, Masera G, Biondi A. Biochemical and genetic defects underlying human congenital hypotransferrinemia. Hematol J 2000;1:390-398
2. Beutler E, Gelbart T, Lee P, Trevino R, Fernandez MA, Fairbanks VF. Molecular characterization of a case of atransferrinemia. Blood 2000;96:4071-4074
3. Fairbanks VF, Brandhagen DJ. Disorders of iron storage and transport. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U (eds). Williams Hematology. New York, McGraw-Hill, 2001
4. Aslan D. Addition of oral iron to plasma transfusion in human congenital hypotransferrinemia: a 10-year observational follow-up with the effects on hematological parameters and growth. Pediatr Blood Cancer 2018;65:e26789
5. Li H, Ginzburg YZ. Crosstalk between iron metabolism and erythropoiesis. Adv Hematol 2010;2010:605435
6. Trombini P, Coliva T, Nemeth E, Mariani R, Ganz T, Biondi A, Piperno A. Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia. Haematologica 2007;92:1407-1410
7. Nemeth E, Ganz T. Hepcidin and iron-loading anemias. Haematologica 2006;91:727-732
8. Bartnikas TB, Andrews NC, Fleming MD. Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice. Blood 2011;117:630-637
9. Coffey R, Ganz T. Erythroferrone: An erythroid regulator of hepcidin and iron metabolism. Hemasphere 2018;2:e35
10. Boshuizen M, van der Ploeg K, von Bonsdorff L, Biemond BJ, Zeerleder SS, van Bruggen R, Juffermans NP. Therapeutic use of transferrin to modulate anemia and conditions of iron toxicity. Blood Rev 2017;31:400-405.